[Wei Fanjie, General Manager of Shanghai Future Industry Fund: Shanghai is the home ground for building a “closed-loop AI pharmaceutical industry”] “Science and Technology Innovation Board Daily” reported on the 15th that at the 19th Pujiang Innovation Forum “Future Pharmaceutical Innovation Forum”, Wei Fanjie, General Manager of Shanghai Future Industry Fund, believed that it will still take time for AI technology to achieve real value doubling in the pharmaceutical industry, and the core of future industry competition will shift to in-depth adaptation of real R&D scenarios and the construction of closed-loop capabilities. Wei Fanjie also mentioned that Shanghai is the home ground for building a "closed-loop AI pharmaceutical industry" and its development advantages in the field of biomedicine are very prominent. It ranks among the top in the industry in terms of overall industry scale, investment and financing activity, number of business cooperation, and total market transactions. (Kechuangban Daily reporter Shi Shiyun)